SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-041787
Filing Date
2022-02-14
Accepted
2022-02-14 16:19:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d316057dsc13g.htm SC 13G 41703
  Complete submission text file 0001193125-22-041787.txt   43110
Mailing Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Subject) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92660 | Film No.: 22632381
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GRAPHITE BIO, INC. 279 EAST GRAND AVENUE, SUITE 430 SOUTH SAN FRANCISCO CA 94080
Business Address
Porteus Matthew (Filed by) CIK: 0001864750 (see all company filings)

Type: SC 13G